| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |